HIP2101 / Hanmi  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HIP2101 / Hanmi
NCT05024721: Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis

Completed
3
326
RoW
HIP2101, RLD2101, HPP2101, HPP2102
Hanmi Pharmaceutical Company Limited
Gastritis
03/22
03/22

Download Options